Sunday, September 22, 2024

Booster dose of self-amplifying SARS-CoV-2 RNA vaccine vs. mRNA vaccine: a phase 3 comparison of ARCT-154 with Comirnaty®

 https://www.medrxiv.org/content/10.1101/2023.07.13.23292597v1

No comments:

Post a Comment